Journal of Nuclear Cardiology

, Volume 4, Issue 1, pp 52–60 | Cite as

A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part II

  • Leslee J. ShawEmail author
  • Eric L. Eisenstein
  • Rory Hachamovitch
  • Gary V. Heller
  • D. Douglas Miller


Indirect Cost Nuclear Cardiology Contribution Margin Relative Risk Ratio Left Main Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 26.
    Shaw LJ, Miller DD, Romeis JC, Kargl D, Younis LT, Chaitman BR. Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease. Ann Intern Med 1994;120:559–66.PubMedGoogle Scholar
  2. 27.
    Christian TF, Miller TD, Bailey KR, Gibbons RJ. Exercise tomographic thallium-201 imaging in patients with severe coronary artery disease and normal electrocardiograms. Ann Intern Med 1994;121:825–32.PubMedGoogle Scholar
  3. 28.
    Hachamovitch R, Berman DS, Kiat H, Bairey-Merz N, Cohen I, Cabico JA, et al. Gender-related differences in clinical management after exercise nuclear testing. J Am Coll Cardiol 1995;26: 1457–64.PubMedCrossRefGoogle Scholar
  4. 29.
    Simes RJ. Confronting publication bias: a cohort design for meta-analysis. Statistics in Medicine 1987;6:11–29.PubMedCrossRefGoogle Scholar
  5. 30.
    Peterson ED, Shaw LJ, Kesler K, Califf RM. Is exercise treadmill testing useful for post-myocardial infarction risk stratification [abstract]? Circulation 1995;92:I-272.Google Scholar
  6. 31.
    Goel V, Deber RB, Detsky AS. Nonionic contrast media: a bargain for some, a burden for many [editorial]. Can Med Assoc J 1990;143:480–1.Google Scholar
  7. 32.
    Powe NR, Davidoff AJ, Moore RD, Brinker JA, Anderson GF, Litt MR, et al. Netcosts from three perspectives of using low versus high osmolality contrast medium in diagnostic angiocardiography. J Am Coll Cardiol 1993;21:1701–9.PubMedGoogle Scholar
  8. 33.
    Mark DB, Lam LC, Hlatky MA, Melton JR, Davidson-Ray L, Woodlief L, et al. Effects of three thrombolytic regimens and two interventional strategies on acute MI costs: results from a prospective randomized trial. Circulation 1991;84(Suppl IV):IV-221.Google Scholar
  9. 34.
    Mark DB, Hlatky MA, Califf RM, Naylor CD, Lee KL, Armstrong PW, et al. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med 1995;332:1418–24.PubMedCrossRefGoogle Scholar
  10. 35.
    Cohen DJ, Breall JA, Ho KK, Weintraub RM, Kuntz RE, Weinstein MC, et al. Economics of elective coronary revascularization: comparison of costs and charges for conventional angioplasty, directional atherectomy, stenting and bypass surgery. J Am Coll Cardiol 1993;22:1052–9.PubMedGoogle Scholar
  11. 36.
    Weinstein MC, Stason WB. Cost-effectiveness of coronary artery bypass surgery. Circulation 1982;66:III-56—66.Google Scholar
  12. 37.
    Goldman L. Cost effective strategies in cardiology. In: Braunwald E, editor. Heart Disease. 4th ed. Philadelphia: WB Saunders, 1992:1694–1707.Google Scholar
  13. 38.
    Kelly ME, Taylor GJ, Moses HW, Mikell FL, Dove JT, Batchelder JE, et al. Comparative cost of myocardial revascularization: percutaneous transluminal angioplasty and coronary artery bypass surgery. J Am Coll Cardiol 1985;5:16–20.PubMedCrossRefGoogle Scholar
  14. 39.
    Black AJR, Roubin GS, Sutor C, Moe N, Jarboe JM, Douglas JS Jr, et al. Comparative costs of percutaneous transluminal coronary angioplasty and coronary artery bypass grafting in multivessel coronary artery disease. Am J Cardiol 1988;62:809–11.PubMedCrossRefGoogle Scholar
  15. 40.
    Finkler SA. The distinction between cost and charges. Ann Intern Med 1982;96:102–9.PubMedGoogle Scholar
  16. 41.
    Hlatky MA, Lipscomb J, Nelson C, Califf RM, Pryor DB, Wallace AG, et al. Resource use and cost of initial coronary revascularization: coronary angioplasty versus coronary bypass surgery. Circulation 1990;82(Suppl IV):IV—208—13.Google Scholar
  17. 42.
    Finkler SA. Cost accounting for health care organizations: concepts and applications. Gaithersburg (MD): Aspen Publishers, 1994.Google Scholar
  18. 43.
    Doubilet P, Weinstein MC, McNeil BL. Use and misuse of the term ‘cost effective’ in medicine. N Engl J Med 1986;314:253–6.PubMedGoogle Scholar
  19. 44.
    Finkler SA. Cost accounting in transition. In: Hospital cost management and accounting: cost accounting for health care organizations. Gaithersburg (MD): Aspen Publishers, 1994;627–30.Google Scholar
  20. 45.
    Ashby JL. The accuracy of cost measures derived from Medicare Cost Report data. Hospital Cost Management and Accounting 1992;3:1–7.Google Scholar
  21. 46.
    Lipscomb J, Copwer T, Mark DB. Comparison of hospital costs with Medicare cost to charge conversions versus a detailed hospital accounting system in patients treated for ischemic heart disease [presentation]. San Diego: Association for Health Services Research, June 11–13, 1994.Google Scholar
  22. 47.
    Mark DB. Economic analysis methods and endpoints. In: Califf RM, Mark DB, Wagner GS, editors. Acute coronary care. 2nd ed. St. Louis: Mosby-Year Book, 1995:167–82.Google Scholar
  23. 48.
    Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. New York: Oxford University Press, 1987.Google Scholar
  24. 49.
    Pettitti DB. Advanced cost-effectiveness analysis. In: Meta-analysis, decision analysis, and cost-effectiveness analysis. New York: Oxford University Press, 1994;169–86.Google Scholar
  25. 50.
    Pryor DB, Shaw L, Harrell FE, Jr, Lee KL, Hlatky MA, Mark DB, et al. Estimating the likelihood of severe coronary artery disease. Am J Med 1991;90:553–62.PubMedGoogle Scholar
  26. 51.
    Eisenberg JM. Clinical economics: a guide to the economic analysis of clinical practices. JAMA 1989;262:2879–86.PubMedCrossRefGoogle Scholar
  27. 52.
    Glaszlou P, Bromwich SL, Simes RJ, for the AUS-TAK Group. Quality of life six months after myocardial infarction treated with thrombolytic therapy. Med J Aust 1994;161:532–6.Google Scholar
  28. 53.
    Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization?: tentative guidelines for using clinical and economic evaluations. Can Med Assoc J 1992;146:473–81.Google Scholar
  29. 54.
    Weinstein MC, Stason WB. Cost-effectiveness of coronary artery bypass surgery [abstract]. Circulation 1992;66(Suppl III):56.Google Scholar
  30. 55.
    Goldman L. Cost effective strategies in cardiology. In: Braunwald E, editor. Heart disease. 4th ed. Philadelphia: WB Saunders, 1992:1694–703.Google Scholar
  31. 56.
    Kassirer JP, Angell M. The journal’s policy on cost-effectiveness analysis [editorial]. N Engl J Med 1994;331:669–70.PubMedCrossRefGoogle Scholar
  32. 57.
    Task Force on Principles for Economic Analysis of Health Care Technology. Economic analysis of health care technology: a report on principles. Ann Intern Med 1995;122:61–70.Google Scholar
  33. 58.
    Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996.Google Scholar

Copyright information

© American Society of Nuclear Cardiology 1997

Authors and Affiliations

  • Leslee J. Shaw
    • 1
    Email author
  • Eric L. Eisenstein
    • 1
  • Rory Hachamovitch
    • 2
  • Gary V. Heller
    • 3
  • D. Douglas Miller
    • 4
  1. 1.Duke University Medical CenterDurham
  2. 2.Cedars-Sinai Medical CenterSt. Louis
  3. 3.Hartford HospitalSt. Louis
  4. 4.St. Louis University Health Sciences CenterSt. Louis

Personalised recommendations